2024 Q4 Form 10-Q Financial Statement

#000152839624000162 Filed on December 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $262.9M $291.5M
YoY Change 26.76% 7.99%
Cost Of Revenue $104.5M $105.1M
YoY Change 9.88% -1.13%
Gross Profit $158.4M $186.4M
YoY Change 41.05% 13.9%
Gross Profit Margin 60.25% 63.95%
Selling, General & Admin $94.23M $100.8M
YoY Change 12.71% 11.06%
% of Gross Profit 59.49% 54.07%
Research & Development $68.88M $75.32M
YoY Change 10.26% 12.72%
% of Gross Profit 43.49% 40.4%
Depreciation & Amortization $5.784M
YoY Change 17.39%
% of Gross Profit 3.1%
Operating Expenses $163.1M $176.1M
YoY Change 11.66% 11.76%
Operating Profit -$4.720M $10.31M
YoY Change -86.03% 69.22%
Interest Expense $10.07M
YoY Change 66.51%
% of Operating Profit 97.67%
Other Income/Expense, Net -$4.055M -$1.504M
YoY Change -70.49% -141.64%
Pretax Income $2.769M $18.88M
YoY Change -107.17% 19.85%
Income Tax -$6.370M $2.125M
% Of Pretax Income -230.05% 11.25%
Net Earnings $9.139M $16.76M
YoY Change -133.76% 37.14%
Net Earnings / Revenue 3.48% 5.75%
Basic Earnings Per Share $0.11
Diluted Earnings Per Share $0.11 $0.20
COMMON SHARES
Basic Shares Outstanding 83.28M shares 83.03M shares
Diluted Shares Outstanding 85.96M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.338B $1.004B
YoY Change 87.72% 25.65%
Cash & Equivalents $823.6M $548.0M
Short-Term Investments $514.8M $455.6M
Other Short-Term Assets $67.60M
YoY Change 8.79%
Inventory
Prepaid Expenses $25.79M
Receivables $97.48M $224.4M
Other Receivables $0.00
Total Short-Term Assets $1.637B $1.296B
YoY Change 67.62% 17.82%
LONG-TERM ASSETS
Property, Plant & Equipment $55.22M $99.16M
YoY Change -0.12% -7.22%
Goodwill $372.2M $372.2M
YoY Change 0.0% 0.0%
Intangibles $7.638M $9.005M
YoY Change -41.72% -37.78%
Long-Term Investments $125.9M
YoY Change -2.25%
Other Assets $64.70M $320.3M
YoY Change 0.4% 8.65%
Total Long-Term Assets $959.4M $930.8M
YoY Change 1.76% 0.27%
TOTAL ASSETS
Total Short-Term Assets $1.637B $1.296B
Total Long-Term Assets $959.4M $930.8M
Total Assets $2.597B $2.226B
YoY Change 35.27% 9.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $31.39M $15.21M
YoY Change 63.43% -56.08%
Accrued Expenses $109.1M
YoY Change 4.91%
Deferred Revenue $224.2M $281.9M
YoY Change 31.03% 36.21%
Short-Term Debt $398.9M
YoY Change
Long-Term Debt Due $398.9M
YoY Change
Total Short-Term Liabilities $615.2M $837.6M
YoY Change 134.49% 124.41%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change -100.0%
Other Long-Term Liabilities $5.490M $45.93M
YoY Change -40.23% -20.8%
Total Long-Term Liabilities $5.490M $45.93M
YoY Change -40.23% -89.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $615.2M $837.6M
Total Long-Term Liabilities $5.490M $45.93M
Total Liabilities $1.329B $883.6M
YoY Change 86.1% 6.66%
SHAREHOLDERS EQUITY
Retained Earnings -$614.9M -$624.1M
YoY Change -4.67% 0.99%
Common Stock $1.895B $1.979B
YoY Change 1.47% 8.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.268B $1.343B
YoY Change
Total Liabilities & Shareholders Equity $2.597B $2.226B
YoY Change 35.27% 9.78%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $9.139M $16.76M
YoY Change -133.76% 37.14%
Depreciation, Depletion And Amortization $5.784M
YoY Change 17.39%
Cash From Operating Activities -$62.31M $193.8M
YoY Change -13.56% 11.86%
INVESTING ACTIVITIES
Capital Expenditures $843.0K $4.430M
YoY Change -15.53% -25.37%
Acquisitions
YoY Change
Other Investing Activities -$2.862M
YoY Change -119.35%
Cash From Investing Activities -$77.60M -$7.292M
YoY Change 179.21% -182.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.041M
YoY Change -102.18%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $415.5M 1.041M
YoY Change -102.18%
NET CHANGE
Cash From Operating Activities -$62.31M 193.8M
Cash From Investing Activities -$77.60M -7.292M
Cash From Financing Activities $415.5M 1.041M
Net Change In Cash $275.6M 187.5M
YoY Change -364.52% 39.65%
FREE CASH FLOW
Cash From Operating Activities -$62.31M $193.8M
Capital Expenditures $843.0K $4.430M
Free Cash Flow -$63.15M $189.3M
YoY Change -13.59% 13.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q4 dei Document Period End Date
DocumentPeriodEndDate
2024-10-31
CY2024Q4 dei Amendment Flag
AmendmentFlag
false
CY2024Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2024Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001528396
CY2024Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-4468504
CY2024Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
970 Park Pl, Suite 200
CY2024Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94403
CY2024Q4 dei City Area Code
CityAreaCode
650
CY2024Q4 dei Local Phone Number
LocalPhoneNumber
357-9100
CY2024Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q4 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q4 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q4 dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
83519257 shares
CY2024Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
823562000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
547992000 usd
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
455576000 usd
CY2024Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1904000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
646000 usd
CY2024Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
97475000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
137339000 usd
CY2024Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
129429000 usd
CY2024Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
87031000 usd
CY2024Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
72059000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
67596000 usd
CY2024Q4 us-gaap Assets Current
AssetsCurrent
1637292000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
1295534000 usd
CY2024Q3 us-gaap Assets
Assets
2226294000 usd
CY2024Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
31394000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
15209000 usd
CY2024Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
51860000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
109084000 usd
CY2024Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
224189000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
281855000 usd
CY2024Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
CY2024Q4 dei Entity Registrant Name
EntityRegistrantName
Guidewire Software, Inc.
CY2024Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q4 us-gaap Short Term Investments
ShortTermInvestments
514767000 usd
CY2024Q3 us-gaap Long Term Investments
LongTermInvestments
125885000 usd
CY2024Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
648000 usd
CY2024Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
55215000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
55409000 usd
CY2024Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
41993000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
43750000 usd
CY2024Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7638000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9005000 usd
CY2024Q4 us-gaap Goodwill
Goodwill
372214000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-27071000 usd
CY2024Q4 us-gaap Senior Notes Current
SeniorNotesCurrent
278595000 usd
CY2024Q3 us-gaap Senior Notes Current
SeniorNotesCurrent
398903000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
32584000 usd
CY2024Q4 us-gaap Liabilities Current
LiabilitiesCurrent
615237000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
837635000 usd
CY2024Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
32934000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
34721000 usd
CY2024Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
671820000 usd
CY2024Q3 us-gaap Senior Long Term Notes
SeniorLongTermNotes
0 usd
CY2024Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3187000 usd
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3628000 usd
CY2024Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5490000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7578000 usd
CY2024Q4 us-gaap Liabilities
Liabilities
1328668000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
883562000 usd
CY2024Q4 us-gaap Common Stock Value
CommonStockValue
8000 usd
CY2024Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1894904000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1979021000 usd
CY2024Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11969000 usd
CY2024Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q4 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value
CY2024Q4 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2024Q3 us-gaap Goodwill
Goodwill
372214000 usd
CY2024Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
274875000 usd
CY2024Q4 us-gaap Assets
Assets
2596697000 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
8000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1342732000 usd
CY2024Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
262901000 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
207407000 usd
CY2024Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
104509000 usd
CY2023Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
95115000 usd
CY2024Q4 us-gaap Gross Profit
GrossProfit
158392000 usd
CY2024Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
San Mateo,
CY2024Q4 dei Trading Symbol
TradingSymbol
GWRE
CY2024Q4 us-gaap Long Term Investments
LongTermInvestments
142119000 usd
CY2024Q3 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
4157000 usd
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
253085000 usd
CY2024Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
64703000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
67255000 usd
CY2024Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
29199000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12244000 usd
CY2024Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-614914000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-624053000 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
1268029000 usd
CY2024Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2596697000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2226294000 usd
CY2024Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
262901000 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
207407000 usd
CY2024Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
104509000 usd
CY2023Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
95115000 usd
CY2024Q4 us-gaap Gross Profit
GrossProfit
158392000 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
112292000 usd
CY2024Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
68880000 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
112292000 usd
CY2024Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
68880000 usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
62469000 usd
CY2024Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
51478000 usd
CY2023Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
44581000 usd
CY2024Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
42754000 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39023000 usd
CY2024Q4 us-gaap Operating Expenses
OperatingExpenses
163112000 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
146073000 usd
CY2024Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-4720000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-33781000 usd
CY2024Q4 gwre Interest Income Nonoperating
InterestIncomeNonoperating
13606000 usd
CY2023Q4 gwre Interest Income Nonoperating
InterestIncomeNonoperating
10613000 usd
CY2024Q4 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2062000 usd
CY2023Q4 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1683000 usd
CY2024Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4055000 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13742000 usd
CY2024Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2769000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38593000 usd
CY2024Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6370000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-11522000 usd
CY2024Q4 us-gaap Profit Loss
ProfitLoss
9139000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-27071000 usd
CY2024Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2024Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2024Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2024Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83276236 shares
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81690912 shares
CY2024Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85960868 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81690912 shares
CY2024Q4 us-gaap Profit Loss
ProfitLoss
9139000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-27071000 usd
CY2024Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-62000 usd
CY2023Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-3507000 usd
CY2024Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
557000 usd
CY2024Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
104000 usd
CY2023Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
173000 usd
CY2024Q4 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
116000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
290000 usd
CY2024Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
275000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2946000 usd
CY2024Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9414000 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30017000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1342732000 usd
CY2024Q4 us-gaap Profit Loss
ProfitLoss
9139000 usd
CY2024Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
38167000 usd
CY2024Q4 gwre Adjustments To Paid In Capital Purchase Of Capped Calls
AdjustmentsToPaidInCapitalPurchaseOfCappedCalls
-58788000 usd
CY2024Q4 gwre Adjustments To Additional Paid In Capital Retirement Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalRetirementOfConvertibleDebt
-79366000 usd
CY2024Q4 gwre Adjustments To Additional Paid In Capital Convertible Debt Issuance Deferred Tax Asset
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtIssuanceDeferredTaxAsset
13931000 usd
CY2024Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-62000 usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
62469000 usd
CY2024Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
51478000 usd
CY2023Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
44581000 usd
CY2024Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
42754000 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39023000 usd
CY2024Q4 us-gaap Operating Expenses
OperatingExpenses
163112000 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
146073000 usd
CY2024Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-4720000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-33781000 usd
CY2024Q4 gwre Interest Income Nonoperating
InterestIncomeNonoperating
13606000 usd
CY2023Q4 gwre Interest Income Nonoperating
InterestIncomeNonoperating
10613000 usd
CY2024Q4 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2062000 usd
CY2023Q4 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1683000 usd
CY2024Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4055000 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13742000 usd
CY2024Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2769000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38593000 usd
CY2024Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6370000 usd
CY2024Q4 us-gaap Profit Loss
ProfitLoss
9139000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-27071000 usd
CY2024Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2024Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2024Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2024Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83276236 shares
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81690912 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81690912 shares
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-27071000 usd
CY2024Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-62000 usd
CY2023Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-3507000 usd
CY2024Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
557000 usd
CY2023Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1024000 usd
CY2024Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
104000 usd
CY2023Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
173000 usd
CY2024Q4 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
116000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
290000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2946000 usd
CY2024Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9414000 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30017000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1342732000 usd
CY2024Q4 us-gaap Profit Loss
ProfitLoss
9139000 usd
CY2024Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1939000 usd
CY2024Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
38167000 usd
CY2024Q4 gwre Adjustments To Paid In Capital Purchase Of Capped Calls
AdjustmentsToPaidInCapitalPurchaseOfCappedCalls
-58788000 usd
CY2024Q4 gwre Adjustments To Additional Paid In Capital Retirement Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalRetirementOfConvertibleDebt
-79366000 usd
CY2024Q4 gwre Adjustments To Additional Paid In Capital Convertible Debt Issuance Deferred Tax Asset
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtIssuanceDeferredTaxAsset
13931000 usd
CY2024Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-62000 usd
CY2024Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
453000 usd
CY2024Q4 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
116000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1199466000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000 usd
CY2024Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
453000 usd
CY2024Q4 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
116000 usd
CY2024Q4 us-gaap Stockholders Equity
StockholdersEquity
1268029000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1199466000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
36199000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3507000 usd
CY2023Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
851000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
290000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1205649000 usd
CY2024Q4 us-gaap Profit Loss
ProfitLoss
9139000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-27071000 usd
CY2024Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5845000 usd
CY2023Q4 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
430000 usd
CY2024Q4 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
5139000 usd
CY2023Q4 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
4064000 usd
CY2024Q4 us-gaap Share Based Compensation
ShareBasedCompensation
38060000 usd
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
36097000 usd
CY2024Q4 gwre Accounts Receivable Net Change To Allowance For Credit Losses And Revenue Reserves
AccountsReceivableNetChangeToAllowanceForCreditLossesAndRevenueReserves
-1257000 usd
CY2023Q4 gwre Accounts Receivable Net Change To Allowance For Credit Losses And Revenue Reserves
AccountsReceivableNetChangeToAllowanceForCreditLossesAndRevenueReserves
-128000 usd
CY2024Q4 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-7955000 usd
CY2023Q4 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-13220000 usd
CY2024Q4 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
3228000 usd
CY2023Q4 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2927000 usd
CY2024Q4 gwre Changes In Fair Value Of Strategic Investments
ChangesInFairValueOfStrategicInvestments
53000 usd
CY2023Q4 gwre Changes In Fair Value Of Strategic Investments
ChangesInFairValueOfStrategicInvestments
0 usd
CY2024Q4 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-286000 usd
CY2023Q4 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
29000 usd
CY2024Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-38609000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-57193000 usd
CY2024Q4 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
38889000 usd
CY2023Q4 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
17250000 usd
CY2024Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6291000 usd
CY2023Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6560000 usd
CY2024Q4 gwre Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-1757000 usd
CY2023Q4 gwre Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-1971000 usd
CY2024Q4 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
16206000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-16982000 usd
CY2024Q4 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-56545000 usd
CY2023Q4 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-54576000 usd
CY2024Q4 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-58107000 usd
CY2023Q4 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-37893000 usd
CY2024Q4 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1685000 usd
CY2024Q4 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-6395000 usd
CY2023Q4 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
701000 usd
CY2024Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-62305000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-72083000 usd
CY2024Q4 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
211649000 usd
CY2023Q4 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
160239000 usd
CY2024Q4 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
139896000 usd
CY2023Q4 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
137386000 usd
CY2024Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
843000 usd
CY2024Q4 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
4233000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3507000 usd
CY2023Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
851000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
290000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1205649000 usd
CY2024Q4 us-gaap Profit Loss
ProfitLoss
9139000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-27071000 usd
CY2024Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5845000 usd
CY2023Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5442000 usd
CY2024Q4 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
545000 usd
CY2023Q4 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
430000 usd
CY2024Q4 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
5139000 usd
CY2023Q4 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
4064000 usd
CY2024Q4 us-gaap Share Based Compensation
ShareBasedCompensation
38060000 usd
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
36097000 usd
CY2024Q4 gwre Accounts Receivable Net Change To Allowance For Credit Losses And Revenue Reserves
AccountsReceivableNetChangeToAllowanceForCreditLossesAndRevenueReserves
-1257000 usd
CY2023Q4 gwre Accounts Receivable Net Change To Allowance For Credit Losses And Revenue Reserves
AccountsReceivableNetChangeToAllowanceForCreditLossesAndRevenueReserves
-128000 usd
CY2024Q4 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-7955000 usd
CY2023Q4 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-13220000 usd
CY2024Q4 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
3228000 usd
CY2023Q4 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2927000 usd
CY2024Q4 gwre Changes In Fair Value Of Strategic Investments
ChangesInFairValueOfStrategicInvestments
53000 usd
CY2023Q4 gwre Changes In Fair Value Of Strategic Investments
ChangesInFairValueOfStrategicInvestments
0 usd
CY2024Q4 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-286000 usd
CY2023Q4 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
29000 usd
CY2024Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-38609000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-57193000 usd
CY2024Q4 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
38889000 usd
CY2023Q4 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
17250000 usd
CY2024Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6291000 usd
CY2023Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6560000 usd
CY2024Q4 gwre Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-1757000 usd
CY2023Q4 gwre Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-1971000 usd
CY2024Q4 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
16206000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-16982000 usd
CY2024Q4 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-56545000 usd
CY2023Q4 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-54576000 usd
CY2023Q4 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-37893000 usd
CY2024Q4 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1685000 usd
CY2023Q4 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1601000 usd
CY2024Q4 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-6395000 usd
CY2023Q4 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
701000 usd
CY2024Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-62305000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-72083000 usd
CY2023Q4 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
160239000 usd
CY2024Q4 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
139896000 usd
CY2023Q4 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
137386000 usd
CY2024Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
843000 usd
CY2023Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
998000 usd
CY2024Q4 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
4233000 usd
CY2023Q4 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
3692000 usd
CY2024Q4 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
772000 usd
CY2023Q4 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
250000 usd
CY2024Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-77601000 usd
CY2023Q4 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
3692000 usd
CY2024Q4 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
772000 usd
CY2023Q4 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
250000 usd
CY2024Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-77601000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27793000 usd
CY2024Q4 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
672750000 usd
CY2023Q4 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
0 usd
CY2024Q4 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
200394000 usd
CY2023Q4 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 usd
CY2024Q4 gwre Payments For Capped Calls
PaymentsForCappedCalls
58788000 usd
CY2023Q4 gwre Payments For Capped Calls
PaymentsForCappedCalls
0 usd
CY2024Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1939000 usd
CY2023Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2024Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
415507000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2024Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-31000 usd
CY2023Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4303000 usd
CY2024Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
275570000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-104179000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
549184000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
406790000 usd
CY2024Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
824754000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
302611000 usd
CY2024Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2604000 usd
CY2023Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
883000 usd
CY2024Q4 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
461000 usd
CY2023Q4 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2805000 usd
CY2024Q4 gwre Capitalized Software Costs Incurred But Not Yet Paid
CapitalizedSoftwareCostsIncurredButNotYetPaid
251000 usd
CY2023Q4 gwre Capitalized Software Costs Incurred But Not Yet Paid
CapitalizedSoftwareCostsIncurredButNotYetPaid
278000 usd
CY2024Q4 gwre Debt Issuance Costs Incurred But Not Yet Paid
DebtIssuanceCostsIncurredButNotYetPaid
1055000 usd
CY2024Q4 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash, cash equivalents, investments, accounts receivable, and unbilled accounts receivable. The Company maintains its cash, cash equivalents, and investments with high-quality financial institutions. The Company is exposed to credit risk for cash held in financial institutions in the event of a default to the extent that such amounts recorded in the condensed consolidated balance sheets are in excess of amounts that are insured by the Federal Deposit Insurance Corporation.</span></div>
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27793000 usd
CY2024Q4 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
672750000 usd
CY2023Q4 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
0 usd
CY2024Q4 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
200394000 usd
CY2023Q4 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 usd
CY2024Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1939000 usd
CY2023Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2024Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
415507000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2024Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-31000 usd
CY2023Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4303000 usd
CY2024Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
275570000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-104179000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
549184000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
406790000 usd
CY2024Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
824754000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
302611000 usd
CY2024Q4 us-gaap Interest Paid Net
InterestPaidNet
2639000 usd
CY2023Q4 us-gaap Interest Paid Net
InterestPaidNet
2500000 usd
CY2024Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2604000 usd
CY2023Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
883000 usd
CY2024Q4 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
461000 usd
CY2023Q4 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2805000 usd
CY2024Q4 gwre Capitalized Software Costs Incurred But Not Yet Paid
CapitalizedSoftwareCostsIncurredButNotYetPaid
251000 usd
CY2023Q4 gwre Capitalized Software Costs Incurred But Not Yet Paid
CapitalizedSoftwareCostsIncurredButNotYetPaid
278000 usd
CY2024Q4 gwre Debt Issuance Costs Incurred But Not Yet Paid
DebtIssuanceCostsIncurredButNotYetPaid
1055000 usd
CY2023Q4 gwre Debt Issuance Costs Incurred But Not Yet Paid
DebtIssuanceCostsIncurredButNotYetPaid
0 usd
CY2024Q4 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing the condensed consolidated financial statements and related disclosures in conformity with GAAP and pursuant to the rules and regulations of the SEC, the Company must make estimates and judgments that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results may differ materially from these estimates.</span></div>
CY2024Q4 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash, cash equivalents, investments, accounts receivable, and unbilled accounts receivable. The Company maintains its cash, cash equivalents, and investments with high-quality financial institutions. The Company is exposed to credit risk for cash held in financial institutions in the event of a default to the extent that such amounts recorded in the condensed consolidated balance sheets are in excess of amounts that are insured by the Federal Deposit Insurance Corporation.</span></div>
CY2024Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
262901000 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
207407000 usd
CY2024Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
262901000 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
207407000 usd
CY2024Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
262901000 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
207407000 usd
CY2024Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
262901000 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
207407000 usd
CY2024Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
130077000 usd
CY2024Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
91188000 usd
CY2024Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
227376000 usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
285483000 usd
CY2024Q3 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
0 usd
CY2024Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
0 usd
CY2024Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
130900000 usd
CY2024Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2000000000 usd
CY2024Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1371696000 usd
CY2024Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1205000 usd
CY2024Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
290000 usd
CY2024Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1372611000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
980025000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
785000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
312000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
980498000 usd
CY2024Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
130077000 usd
CY2024Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
91188000 usd
CY2024Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
227376000 usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
285483000 usd
CY2024Q3 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
0 usd
CY2024Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
0 usd
CY2024Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
130900000 usd
CY2024Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2000000000 usd
CY2024Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1371696000 usd
CY2024Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1205000 usd
CY2024Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
290000 usd
CY2024Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1372611000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
980025000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
785000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
312000 usd
CY2024Q4 gwre Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date Less Than12 Months
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateLessThan12Months
1230492000 usd
CY2024Q4 gwre Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date Greater Than12 Months
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateGreaterThan12Months
142119000 usd
CY2024Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1372611000 usd
CY2024Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
715725000 usd
CY2024Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
514767000 usd
CY2024Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
142119000 usd
CY2024Q4 gwre Cash Cash Equivalents And Debt Securities Available For Sale
CashCashEquivalentsAndDebtSecuritiesAvailableForSale
1372611000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
399037000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
455576000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
125885000 usd
CY2024Q3 gwre Cash Cash Equivalents And Debt Securities Available For Sale
CashCashEquivalentsAndDebtSecuritiesAvailableForSale
980498000 usd
CY2023Q4 gwre Changes In Fair Value Of Strategic Investments
ChangesInFairValueOfStrategicInvestments
0 usd
CY2024Q4 us-gaap Gain Loss On Investments
GainLossOnInvestments
53000 usd
CY2023Q4 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
CY2024Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
19513000 usd
CY2024Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
18740000 usd
CY2024Q4 gwre Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date Less Than12 Months
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateLessThan12Months
1230492000 usd
CY2024Q4 gwre Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date Greater Than12 Months
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateGreaterThan12Months
142119000 usd
CY2024Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1372611000 usd
CY2024Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
715725000 usd
CY2024Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
514767000 usd
CY2024Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
142119000 usd
CY2024Q4 gwre Cash Cash Equivalents And Debt Securities Available For Sale
CashCashEquivalentsAndDebtSecuritiesAvailableForSale
1372611000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
399037000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
455576000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
125885000 usd
CY2024Q3 gwre Cash Cash Equivalents And Debt Securities Available For Sale
CashCashEquivalentsAndDebtSecuritiesAvailableForSale
980498000 usd
CY2024Q4 gwre Changes In Fair Value Of Strategic Investments
ChangesInFairValueOfStrategicInvestments
53000 usd
CY2023Q4 gwre Changes In Fair Value Of Strategic Investments
ChangesInFairValueOfStrategicInvestments
0 usd
CY2024Q4 us-gaap Gain Loss On Investments
GainLossOnInvestments
53000 usd
CY2023Q4 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
CY2024Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
19513000 usd
CY2024Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
18740000 usd
CY2024Q4 us-gaap Profit Loss
ProfitLoss
9139000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-27071000 usd
CY2024Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2024Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2024Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83276236 shares
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81690912 shares
CY2024Q4 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
785004 shares
CY2023Q4 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2024Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85960868 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81690912 shares
CY2024Q3 gwre Indemnification Agreement Reimbursement Paid
IndemnificationAgreementReimbursementPaid
0 usd
CY2024Q4 gwre Indemnification Agreement Reimbursement Paid
IndemnificationAgreementReimbursementPaid
0 usd
CY2024Q4 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
0 customer
CY2024Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
38167000 usd
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
36199000 usd
CY2024Q4 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
107000 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
102000 usd
CY2024Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
38060000 usd
CY2023Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
36097000 usd
CY2024Q4 us-gaap Share Based Compensation
ShareBasedCompensation
38060000 usd
CY2024Q4 us-gaap Profit Loss
ProfitLoss
9139000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-27071000 usd
CY2024Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2024Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2024Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83276236 shares
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81690912 shares
CY2024Q4 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
785004 shares
CY2023Q4 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2024Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85960868 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81690912 shares
CY2024Q3 gwre Indemnification Agreement Reimbursement Paid
IndemnificationAgreementReimbursementPaid
0 usd
CY2024Q4 gwre Indemnification Agreement Reimbursement Paid
IndemnificationAgreementReimbursementPaid
0 usd
CY2024Q4 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
0 customer
CY2024Q3 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
0 customer
CY2024Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
38167000 usd
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
36199000 usd
CY2024Q4 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
107000 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
102000 usd
CY2024Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
38060000 usd
CY2023Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
36097000 usd
CY2024Q4 us-gaap Share Based Compensation
ShareBasedCompensation
38060000 usd
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
36097000 usd
CY2024Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
371681000 usd
CY2024Q4 us-gaap Share Price
SharePrice
186.26
CY2024Q3 us-gaap Share Price
SharePrice
150.07
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.360
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.350
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.034
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.045
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2024Q4 us-gaap Share Price
SharePrice
186.26
CY2024Q3 us-gaap Share Price
SharePrice
150.07
CY2024Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
36097000 usd
CY2024Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
371681000 usd
CY2024Q4 us-gaap Share Price
SharePrice
186.26
CY2024Q3 us-gaap Share Price
SharePrice
150.07
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.360
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.350
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.034
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2024Q4 us-gaap Share Price
SharePrice
186.26
CY2024Q3 us-gaap Share Price
SharePrice
150.07
CY2024Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
gwre-20241031_def.xml Edgar Link unprocessable
0001528396-24-000162-index-headers.html Edgar Link pending
0001528396-24-000162-index.html Edgar Link pending
0001528396-24-000162.txt Edgar Link pending
0001528396-24-000162-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gwre-20241031.htm Edgar Link pending
gwre-20241031.xsd Edgar Link pending
gwreex191insidertradingp.htm Edgar Link pending
gwreex191insidertradingp001.jpg Edgar Link pending
gwreex191insidertradingp002.jpg Edgar Link pending
gwreex191insidertradingp003.jpg Edgar Link pending
gwreex191insidertradingp004.jpg Edgar Link pending
gwreex191insidertradingp005.jpg Edgar Link pending
gwreex191insidertradingp006.jpg Edgar Link pending
gwreex191insidertradingp007.jpg Edgar Link pending
gwreex191insidertradingp008.jpg Edgar Link pending
gwreex191insidertradingp009.jpg Edgar Link pending
gwreex191insidertradingp010.jpg Edgar Link pending
gwreex191insidertradingp011.jpg Edgar Link pending
gwreex191insidertradingp012.jpg Edgar Link pending
gwreex191insidertradingp013.jpg Edgar Link pending
gwreex191insidertradingp014.jpg Edgar Link pending
gwreex191insidertradingp015.jpg Edgar Link pending
gwreex191insidertradingp016.jpg Edgar Link pending
gwreex191insidertradingp017.jpg Edgar Link pending
gwreex191insidertradingp018.jpg Edgar Link pending
gwreex191insidertradingp019.jpg Edgar Link pending
gwreex31110312024-10q.htm Edgar Link pending
gwreex31210312024-10q.htm Edgar Link pending
gwreex32110312024-10q.htm Edgar Link pending
gwreex996compensationrec.htm Edgar Link pending
gwreex996compensationrec001.jpg Edgar Link pending
gwreex996compensationrec002.jpg Edgar Link pending
gwreex996compensationrec003.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gwre-20241031_pre.xml Edgar Link unprocessable
gwre-20241031_htm.xml Edgar Link completed
gwreex996compensationrec004.jpg Edgar Link pending
gwreex996compensationrec005.jpg Edgar Link pending
gwreex996compensationrec006.jpg Edgar Link pending
gwreex996compensationrec007.jpg Edgar Link pending
gwreex996compensationrec008.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
gwre-20241031_cal.xml Edgar Link unprocessable
gwre-20241031_lab.xml Edgar Link unprocessable